{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:12:01Z","timestamp":1791043921380,"version":"4.1.0"},"reference-count":20,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,2,22]],"date-time":"2010-02-22T00:00:00Z","timestamp":1266796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Cosmetic Dermatology"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Antioxidants are becoming increasingly important in the treatment of skin disease. In addition to their known anti\u2010inflammatory effects, antioxidants may act to prevent the oxidation of sebum which has been proposed to be comedogenic in acne patients. Sodium L\u2010ascorbyl\u20102\u2010phosphate (APS) is a stable vitamin C derivative and highly effective antioxidant that has demonstrated efficacy in acne in open label studies.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> To evaluate the efficacy and safety of APS 5% lotion for the treatment of acne in a blinded controlled study.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> A total of 50 subjects were randomized in a double\u2010blind controlled trial to receive APS 5% lotion or vehicle for 12\u2003weeks. Evaluation included an Investigator\u2019s Global Assessment Score, a Subjects\u2019 Global Assessment Score, lesion counts, cutaneous tolerability, and adverse events.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> APS 5% lotion demonstrated statistically significant improvement when compared to vehicle in all of the parameters measured. The adverse event frequency and cutaneous tolerability profile for APS 5% lotion were similar to vehicle.<\/jats:p><jats:p><jats:bold>Limitations\u2002<\/jats:bold> Adjunctive topical or oral agents and their impact on acne were not studied in this trial.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> This study demonstrates that 5% sodium L\u2010ascorbyl\u20102\u2010phosphate is efficacious as monotherapy for the treatment of acne. APS 5% lotion offers a novel addition to our current acne armamentarium.<\/jats:p>","DOI":"10.1111\/j.1473-2165.2010.00480.x","type":"journal-article","created":{"date-parts":[[2010,2,22]],"date-time":"2010-02-22T07:33:18Z","timestamp":1266823998000},"page":"22-27","source":"Crossref","is-referenced-by-count":22,"title":["Sodium L\u2010ascorbyl\u20102\u2010phosphate 5% lotion for the treatment of acne vulgaris: a randomized, double\u2010blind, controlled trial"],"prefix":"10.1111","volume":"9","author":[{"given":"Heather","family":"Woolery\u2010Lloyd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ikeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,2,22]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1986.tb04060.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1986.tb04061.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12285793"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2340\/0001555572178179","article-title":"Effect of doxycycline on the generation of reactive oxygen species: a possible mechanism of action of acne therapy with doxycycline","volume":"72","author":"Akamatsu H","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(03)00063-2"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.22.1301"},{"key":"e_1_2_6_8_2","volume-title":"An Open Study Comparing Efficacy of 5% Sodium L\u2010Ascorbyl\u20102\u2010Phosphate Lotion Versus 1% Clindamycin Phosphate Lotion and Vehicle Lotion in the Treatment of Acne Vulgaris","author":"Ikeno H","year":"2003"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-2494.2005.00263.x"},{"key":"e_1_2_6_10_2","first-page":"43","article-title":"Open study comparing 5% sodium L\u2010ascorbyl\u20102\u2010phosphate lotion versus 1% clindamycin phosphate lotion for acne vulgaris","volume":"19","author":"Ikeno H","year":"2006","journal-title":"J Cosmet Dermatol"},{"key":"e_1_2_6_11_2","first-page":"368","article-title":"Open study comparing 5% sodium L\u2010ascorbyl\u20102\u2010phosphate lotion versus Adapalene 0.1% gel for acne vulgaris","volume":"20","author":"Ikeno H","year":"2007","journal-title":"J Cosmet Dermatol"},{"key":"e_1_2_6_12_2","first-page":"83","article-title":"Evaluation of clinical efficacy of combination treatment with clindamycin lotion plus vitamin C derivative lotion","volume":"8","author":"Ikeno H","year":"1998","journal-title":"Aesthet Dermatol Japan"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1954.01540210103019"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4157(88)90014-7"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12371744"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(96)01904-8"},{"issue":"2","key":"e_1_2_6_17_2","first-page":"51","article-title":"Final report of the safety assessment of l\u2010ascorbic acid, calcium ascorbate, magnesium ascorbate, magnesium ascorbyl phosphate, sodium ascorbate, and sodium ascorbyl phosphate as used in cosmetics","volume":"24","author":"Elmore AR","year":"2005","journal-title":"Int J Toxicol"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2005.31725"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2001.tb00105.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1708-8240.1998.tb00355.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90830-0"}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1473-2165.2010.00480.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1473-2165.2010.00480.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T20:08:03Z","timestamp":1698955683000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1473-2165.2010.00480.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,22]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1473-2165.2010.00480.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1473-2165.2010.00480.x","archive":["Portico"],"relation":{},"ISSN":["1473-2130","1473-2165"],"issn-type":[{"value":"1473-2130","type":"print"},{"value":"1473-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,22]]}}}